Precipio Inc

PRPO

Company Profile

  • Business description

    Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

  • Contact

    4 Science Park
    New HavenCT06511
    USA

    T: +1 203 787-7888

    E: [email protected]

    https://www.precipiodx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    60

Stocks News & Analysis

stocks

Avoid this overpriced ASX share

This ASX share is 84% overvalued and lacks a sustainable competitive advantage.
stocks

Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm

A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.
stocks

Baidu: Moat downgraded to none from wide; AI segment growth to offset search decline in long \run

We’ve also lowered our fair value estimate of Baidu stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,924.208.30-0.09%
CAC 408,089.26173.902.20%
DAX 4024,035.07625.702.67%
Dow JONES (US)47,998.68257.880.54%
FTSE 10010,433.15183.631.79%
HKSE25,959.90551.442.17%
NASDAQ22,843.75147.810.65%
Nikkei 22554,248.391,519.672.88%
NZX 50 Index13,094.374.46-0.03%
S&P 5006,824.0628.070.41%
S&P/ASX 2008,692.6011.80-0.14%
SSE Composite Index4,123.1426.540.65%

Market Movers